Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer

Overview of attention for article published in Frontiers in oncology, September 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,023 followers.

Hi all, we finally finished our special issue in @FronOncology. Thanks Jean for putting this up so I can just retweet.

15 Sep 2021

Reply Repost Favourite

New research: Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer https://t.co/z1RPGVxwNw #oncology

15 Sep 2021

Reply Repost Favourite

Happy to share our editorial @FrontOncology on Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer. A series of great papers describing the trends and advances in this field. Check out. https://t.co/u5Zi1jfmNu

15 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.